A 'game changing' new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time -- and could lead to the first new class of antibiotic drug in 30 years.
Researchers have used a combination of light and genetic engineering to controlling the metabolism, or basic chemical process, of a living cell. Building on techniques that already have transformed the field of neuroscience, the researchers used light to control genetically-modified yeast and increase its output of commercially valuable chemicals.
Working with light and genetically engineered bacteria, researchers are able to shape the growth of bacterial communities. From polka dots to stripes to circuits, they can render intricate designs overnight.